Loading song details...
Dose Escalation And Expansion Study Of 225Ac J591 In MCRPC
No description available.
MP3 Download
Video Download
Related Songs
5:28
Clinical Trials A Principal Investigator Explains Dose Escalation Phase By
6:04
Dose Escalation Managing Toxicities Of Neratinib
2:02
Phase I Dose Escalation And Expansion Study Evaluating BI 907828 In Patients With Solid Tumours
1:34
Dose Escalation And Expansion Study Of Ivosidenib In Patients With IDH1 Mutant MDS
1:53
ARTFORCE Rationale And Study Design Of Radiotherapy Dose Escalation Toxicity Risks For HNC
3:33
Dose Escalation And Tolerance In The Use Of Opioid Drugs Pain Relief
3:56
Sayeh Lavasani MD MS Neratinib And Dose Escalation Optimizing Therapy For HER2 Disease
1:00:50
Design Of Adaptive Phase 1 Clinical Trials For Dose Escalation Using The DEDUCE Application
2:28
What Is Dose Escalation In Phase 1 Clinical Trials And Treatments Uncovered
22:00
Dose Escalation Design With Consideration Of Late Onset Toxicity
55:14
Designs Of Dose Escalation Studies In Phase I Oncology Trials
8:47
Sramila Aithal MD Neratinib And Dose Escalation Optimizing Therapy For HER2 Disease
5:23
Phase I Dose Escalation Study Of Fractionated 225Ac J591 For MCRPC
6:46
Yifan Tu MD Neratinib And Dose Escalation Optimizing Therapy For HER2 Disease
6:57
Best Practices For Optimizing Dose Escalation In First Human Studies
1:16
Modern Dose Escalation Phase 1 Trials With East ESCALATE
1:28:14
Phase 1 Dose Escalation Introduction To Adaptive Trial Designs Using FACTS
1:22
Dr Miller On MDD With Dose Escalation
43:29
Phase 1 Dose Escalation Trials With ESCALATE
2:54